Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

I think it simply means LCI is focusing efforts on their Concerta

How about a deeper dive rather than that of opinion?

In May 2019, the same month as LCI announced it was initiating their commercialization of their own version of Concerta and Elite's IR, their quarterly report showed their CNS drug portfolio accounted for 5% of their total revenues. (OBTW: Andor Pharma is the company for whom they market Concerta)
https://seekingalpha.com/pr/17526653-lannett-commences-marketing-generic-concerta

In May 2021 (that is two years later), they have added Elite's XR and their CNS drugs are now 22% of their total revenues. OBTW: as they noted, the pandemic has impacted scripts across the board. So we might speculate that their total CNS revenues would be higher in a post-pandemic US.

Having a more expanded portfolio makes their commercialization effort more efficient because they have a line of CNS drugs rather than a single one. They would not simply focus on a single drug when they have a larger portfolio, that would be inexcusable and they know the value of selling bulk products at a competitive price. That is the value of generics.

So, no. LCI is not merely focusing on Concerta. That is not how commercialization works. When you have a line of products you leverage price, a simpler supply chain, and consistent service. That is how a mature business like the 77 year old Lannett operates and it is why Elite partnered with them.